Featured Studies
ASCO: Cancer-killing poliovirus combination shrinks breast tumors in Duke-led mouse trials
Recent data showed that Merck’s checkpoint inhibitor Keytruda cuts the risk of death significantly in newly diagnosed lung cancer patients and Bristol-Myers Squibb made a case for Opdivo combos.
Read More